Paradoxical pyoderma gangrenosum secondary to adalimumab successfully treated with methotrexate: A case report
Modern Rheumatology Case Reports · 2025
DOI: 10.1093/mrcr/rxae073 ↗Kurz gefasst
Fallbericht in der Zeitschrift Modern Rheumatology Case Reports, 2025. Verfasst von Kristy El Morr und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Faculty of medicine and medical sciences, University of Balamand, Balamand, Lebanon. Hauptthemen laut MEDLINE: Adalimumab, Pyoderma Gangrenosum, Methotrexate, Antirheumatic Agents. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Pyoderma gangrenosum (PG) is a rare inflammatory skin disorder, categorised under neutrophilic dermatoses. It can be idiopathic or associated with underlying conditions like inflammatory bowel disease, autoimmune diseases, and certain cancers. Some medications, including tumour necrosis factor-alpha inhibitors like adalimumab, can also induce this paradoxical reaction. We describe the case of a 19-year-old male with adalimumab-induced PG, which was successfully treated with methotrexate, contributing to the understanding of drug-induced PG and alternative treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Faculty of medicine and medical sciences, University of Balamand, Balamand, Lebanon.
- Clemenceau Medical Center, Johns Hopkins International, Beirut PO BOX 11-2555, Lebanon.
ORCID-Profile: Mohamad Ali Rida
Zitieren
APA
El Morr, K., & Rida, M. A. (2025). Paradoxical pyoderma gangrenosum secondary to adalimumab successfully treated with methotrexate: A case report. Modern Rheumatology Case Reports. https://doi.org/10.1093/mrcr/rxae073
Vancouver
El Morr K, Rida MA. Paradoxical pyoderma gangrenosum secondary to adalimumab successfully treated with methotrexate: A case report. Modern Rheumatology Case Reports. 2025. doi:10.1093/mrcr/rxae073
BibTeX
@article{ElMorr2025,
author = {El Morr, Kristy and Rida, Mohamad Ali},
title = {Paradoxical pyoderma gangrenosum secondary to adalimumab successfully treated with methotrexate: A case report},
journal = {Modern Rheumatology Case Reports},
year = {2025},
doi = {10.1093/mrcr/rxae073}
}
EUVIMED